Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cambrex Corp (NYSE:CBM)

60.55
Delayed Data
As of Jun 26
 +0.15 / +0.25%
Today’s Change
38.30
Today|||52-Week Range
62.95
+12.23%
Year-to-Date

Today’s Trading

Previous close60.40
Today’s open60.65
Day’s range59.97 - 61.30
Volume152,523
Average volume (3 months)306,828
Market cap$2.0B
Dividend yield--
Data as of 06/26/2017

Growth & Valuation

Earnings growth (last year)+40.91%
Earnings growth (this year)+5.14%
Earnings growth (next 5 years)+13.50%
Revenue growth (last year)+13.23%
P/E ratio21.4
Price/Sales3.63
Price/Book4.83

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC+0.29+2.47%
AERIAerie Pharmaceutical...0.000.00%
SRPTSarepta Therapeutics...-0.37-1.06%
PCRXPacira Pharmaceutica...0.000.00%
Data as of 06/26/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.76
Annual revenue (last year)$490.6M
Annual profit (last year)$81.7M
Net profit margin17.80%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
President, Chief Executive Officer &
Director
Steven M. Klosk
Chief Operating Officer &
Executive Vice President
Shawn P. Cavanagh
Corporate headquarters
East Rutherford, New Jersey

Forecasts